Kopran Quarterly Results for Trading Insights

KOPRAN • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-10 Cr
QSept 2025
Quarterly Results

Kopran Quarterly Results Key Highlights

  • Revenue of ₹118 Cr in Sept 2025 (-33.0% vs Mar 2025, -22.9% vs Sept 2024)
  • Net Profit of ₹-10 Cr in Sept 2025 (-200.0% vs Mar 2025, -242.9% vs Sept 2024)
  • EBITDA of ₹-5 Cr in Sept 2025 (-125.0% vs Mar 2025)
  • Operating Margin of -4.0% in Sept 2025 (-14.0pp vs Mar 2025)
  • Earnings Per Share of ₹-2.06 in Sept 2025 (-202.5% vs Mar 2025)

Kopran Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Sept 2024 Mar 2024 QoQ YoY
Revenue (₹ Cr) 118 176 138 153 196 -33.0% -22.9%
Net Profit (₹ Cr) -10 10 7 7 19 - -
EBITDA (₹ Cr) -5 20 17 16 31 - -
EPS (₹) -2.06 2.01 1.54 1.53 3.86 - -
Operating Margin (%) -4.0% 10.0% 10.0% 10.0% 12.0% - -

Kopran Share Price Trend Around Quarterly Results

Visualize Kopran's 1-year price movement across quarterly results — ideal for logging trades in Kopran share price chart using Tickjournal. All values in ₹.

Profitability Ratios

Profit Margin -8.5%
EBITDA Margin -4.2%
Operating Margin -4.0%
ROE (Annual) -7.7%

Balance Sheet Highlights

Total Assets ₹844 Cr
Total Equity ₹518 Cr
Current Assets ₹510 Cr
Current Liabilities ₹37 Cr

Cash Flow Analysis

Operating Cash Flow ₹42 Cr
Investing Cash Flow ₹-56 Cr
Financing Cash Flow ₹26 Cr
Net Cash Flow ₹11 Cr

Current Market Data

Current Price ₹149.16
Exchange NSE
Last Updated Jan 09, 2026

Sector Competitors - Quarterly Performance Comparison

Comparing Kopran quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025
₹417,052.40 Cr 1729.9 14,875 3,125 +10.8% - 21.0% 133.1
Divis Laboratories
Sept 2025
₹176,337.50 Cr 6616.5 2,860 689 +7.1% - 24.1% 254.8
Torrent Pharmaceuti…
Sept 2025
₹136,522.12 Cr 3963.4 3,219 591 +11.3% - 18.4% 226.0
Cipla
Sept 2025
₹118,572.82 Cr 1465.7 7,716 1,353 +12.0% - 17.5% 87.6
Dr Reddys Laborator…
Sept 2025
₹100,998.62 Cr 1210.1 9,135 1,337 +1.1% - 14.6% 74.8
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores